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Creating artificial protein families affords new opportunities to explore the determinants of structure and biological
function free from many of the constraints of natural selection. We have created an artificial family comprising ;3,000
P450 heme proteins that correctly fold and incorporate a heme cofactor by recombining three cytochromes P450 at
seven crossover locations chosen to minimize structural disruption. Members of this protein family differ from any
known sequence at an average of 72 and by as many as 109 amino acids. Most (.73%) of the properly folded chimeric
P450 heme proteins are catalytically active peroxygenases; some are more thermostable than the parent proteins. A
multiple sequence alignment of 955 chimeras, including both folded and not, is a valuable resource for sequence-
structure-function studies. Logistic regression analysis of the multiple sequence alignment identifies key structural
contributions to cytochrome P450 heme incorporation and peroxygenase activity and suggests possible structural
differences between parents CYP102A1 and CYP102A2.
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Introduction
Our understanding of how protein sequence relates to
structure and function is aided by comparisons of sequences
related by evolution [1,2]. With only limited numbers of
highly divergent sequences, however, such analyses are often
uninformative. Furthermore, because the sequences have
been culled by natural selection, relationships between
sequence and physical or chemical properties not under
direct selection are difficult or impossible to discern. We
would like to create artificial protein families in order to
probe the range of sequence and functional diversity that is
compatible with a given structure, free from the constraint of
having to function in the narrow context of the host
organism. These artificial sequences would help us to identify
connections to functions that may not be important bio-
logically (e.g., high thermostability, new substrate specificity,
or ability to fold into a particular structure, but not catalyze a
particular reaction), but are critical for understanding the
proteins themselves [3,4].
The products of millions of years of divergence and natural
selection, protein families contain members that differ at
large numbers of amino acids residues. Creating numerous
diverse and folded sequences in the laboratory is challenging,
due in part to the sparsity of proteins in sequence space.
Among random sequences, estimates of the frequency of
functional proteins range from 1 in 1011 [5] to as little as 1 in
1077 [6]. Randomly mutating a functional parent sequence
improves the odds, but highly mutated sequences are still
exceedingly unlikely to fold into recognizable proteins [7,8].
The methods by which novel proteins have been created,
including selection from libraries of random [5] or patterned
[9] sequences, evolution from existing sequences by iterative
mutation or recombination [10], and by structure-guided
design [11] as well as computation-intensive protein design
[12,13], either yield small numbers of characterized sequences
or numerous sequences with low diversity (few sequence
changes).
We are developing site-directed, homologous recombina-
tion guided by structure-based computation (SCHEMA) [14–
16] to create libraries of protein sequences that are
simultaneously highly mutated and have a high likelihood of
folding into the parental structure. Mutations made by
recombination of functional sequences are much more likely
to be compatible with the particular protein fold than are
random mutations [17]. SCHEMA calculations allow us to
minimize the number of structural contacts that are
disrupted when portions of the sequence are inherited from
different parents, further increasing the probability that the
chimeric proteins will fold. The validity of the SCHEMA
disruption metric has been demonstrated in previous work
[14–16]. SCHEMA, however, has not yet been used to design a
library to maximize the number of sequences with low
disruption and high mutation.
Here we report SCHEMA-guided recombination of three
cytochromes P450 to create 6,561 chimeras, of which ;3,000
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are properly folded P450 proteins. Cytochromes P450
comprise a superfamily of heme enzymes with myriad
biological functions, including key roles in drug metabolism,
breakdown of xenobiotics, and steroid and secondary
metabolite biosynthesis [18]. More than 4,500 sequences of
this ubiquitous enzyme are known [19]. Members of the
artificial family of chimeric P450s reported here differ from
any known protein by up to 109 amino acids, yet most retain
significant catalytic activity. Unlike natural protein families,
this artificial family also includes sequences that do not fold
or function. Inclusion of nonfunctional sequences enables us
to apply powerful logistic regression tools [20] to the multiple
sequence alignment (MSA) of the laboratory-generated
proteins and determine which elements contribute to correct
heme incorporation and retention of catalytic activity in the
cytochrome P450 heme domain.
Results/Discussion
SCHEMA Design and Construction of a Chimeric P450
Library
We generated an artificial family of cytochromes P450 by
recombining fragments of the genes encoding the heme-
binding domains of three bacterial P450s, CYP102A1 (also
known as P450BM3), CYP102A2, and CYP102A3 (abbreviated
A1, A2, and A3), which share ;65% amino acid identity
[21,22] (Figure 1). The parent proteins are 463–466 amino
acids long and contain the single substitution F87A (A1) or
F88A (A2 and A3), which increases the peroxygenase activities
of these heme domains [23]. Calculations of the SCHEMA
disruption that results when residue–residue contacts present
in the parent structure are broken by recombination (see
Materials and Methods) served to guide the placement of
crossovers so as to maximize the number of highly mutated,
folded proteins in the resulting library.
To accomplish this, we used the structure of the heme
domain from CYP102A1 [24] to computationally evaluate
5,000 libraries with seven crossovers, each of which contained
38 ¼ 6,561 chimeric sequences (including the parents).
Crossover sites were chosen randomly, with a minimum
fragment size of 20 residues. To estimate the fraction of
folded proteins in each library, we counted the number of
structural contacts, E, disrupted in each chimeric sequence
(see Materials and Methods) [14,16]. Based on data from 17
A1–A2 chimeras individually constructed and studied pre-
viously [25], we modeled the probability of folding as a step
function which decreases from 1 to 0 at a threshold of E¼ 30.
Fraction folded was thus calculated as the number of
chimeras in each library with E  30 divided by the total
number of chimeras (¼ 6,561). The average number of amino
acid substitutions from the closest parent ,m. for the
folded proteins (those with E  30) was also calculated as a
measure of the library sequence diversity.
From the set of 5,000 randomly generated libraries, we
selected only those with a fraction folded greater than 25%
for further study. Within these, 14 crossover locations
dominated, appearing in more than 40% of the libraries.
Using these 14 crossover sites, we evaluated all 3,432 possible
seven-crossover libraries and chose one with a high fraction
folded (40%), high diversity (,m.¼ 68 for the chimeras with
E  30,,m.¼76.4 for the library as a whole), and crossovers
distributed over the primary sequence (average number of
residues per block¼ 59 6 10). The final design has crossovers
located after residues Glu64, Ile122, Tyr166, Val216, Thr268,
Ala328, and Gln404, based on the numbering of the A1
sequence (Figure 1A).
The individual structural elements identified by SCHEMA
are not obvious based on secondary or domain structure
(Figures 2 and 3A). For example, the crossovers between
blocks 2–3, 4–5, 5–6, and 7–8 lie within the D, G, I and L
helices, respectively [26]. Individual blocks, however, combine
to form larger structural elements that coincide with protein
domains determined from inspection of the A1 crystal
structure [26] and concerted motions evident in molecular
Figure 1. Diverse Chimeras Created by Site-Directed Recombination
(A) Site-directed recombination of three bacterial cytochromes P450 showing crossover sites chosen to minimize the number of disrupted contacts
(number is last residue of the sequence block according to CYP102A1 numbering). Blocks are assigned numbers 1 through 8 and three fragments are
possible at each block. Three example chimeras are shown to illustrate the fragment nomenclature, e.g., fragment 1.3 is block 1 inherited from parent
A3.
(B) Sequences of three parents and 97 folded P450 chimeras and number of amino acid changes relative to the closest parent (bar on right).
DOI: 10.1371/journal.pbio.0040112.g001
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dynamics simulations of the same protein [27] (Figure 3A).
Blocks 1 and 7 comprise the independent ‘‘b domain,’’ most
of which is a five-stranded b-sheet. The two-stranded, anti-
parallel b-sheet comes from block 7, while the remaining
three b-strands are contributed by block 1. The library design
divided this domain into the fewest possible pieces. The
remaining blocks comprise the ‘‘a domain’’ [26], which on the
basis of concerted protein motions has been divided further
into a9 (corresponding to blocks 4 and 5) and a 99 domains
(blocks 6 and 8) [27]. These three domains reflect groups of
residues that move together not only in molecular dynamic
simulations but also between different conformations of A1,
which undergoes a large conformational change upon
substrate binding [28]. Considering the root-mean-square
deviation (RMSD) between the substrate-bound (closed) and
substrate-free (open) forms of A1 (Figure 3B) [29], five of
seven crossovers are in regions which move 1.2 A˚ or less,
significantly less than the average displacement of 2.2 A˚, and
capture the boundaries of the previously defined domains
within six residues.
The three gene fragments encoding each of the eight blocks
were combinatorially assembled using the sequence-inde-
pendent site-directed chimeragenesis (SISDC) [30] method
developed specifically for this application to generate a gene
library containing 6,561 different sequences (Figure 1A).
These genes were expressed in Escherichia coli, where high-
throughput sequencing by DNA probe hybridization and
functional assays determined the sequences and functions of
the proteins they encoded.
Sequence Analysis
Because the crossover locations are fixed, the complete
sequence of a chimera (absent any point mutations, in-
sertions, or deletions) can be obtained by determining which
parent sequence is present at each block by DNA probe
hybridization [31]. Out of 1,512 randomly selected colonies
analyzed this way, 754 complete sequences were obtained. Of
these, 628 were unique. The distribution of fragments in this
sample revealed two main biases from the ideal incorporation
of 33% of each parent at each block (Figure S1): at block 1,
parent A1 is present in 10% of the chimeras, while parent A2
is present at block 4 in only 0.5%.
We completely sequenced 39 chimeras in order to assess
the frequency of point mutations and of insertions, deletions,
and remaining tag sequences (indels). Tag sequences were
inserted at each crossover location for library construction by
SISDC, and any remaining tag sequences result in a large
insertion. In seven randomly chosen chimeras we found only
one synonymous point mutation and no indels. We also
sequenced 32 randomly chosen chimeras for which folding
status had been determined. Twenty of these encoded folded
P450s, while 12 encoded proteins that were not P450s. In the
20 folded P450 sequences, there were zero remaining tag
indels and two point mutations. In the 12 not-folded
sequences, one point mutation and one remaining tag
sequence were found. From the overall point mutation
frequency of 0.007% (in 51,568 nucleotides), we estimate
that fewer than 10% of the chimeras in the library contain a
point mutation. No indels or tag sequences were found in any
of the folded P450 sequences, and fewer than 9% of the not
folded chimeras contain indels or tags. Comparing the results
from DNA sequencing and probe hybridization analysis, we
Figure 2. Structural Model of Heme-Domain Backbone Structure
Showing Positions of Each Block
Model is based on the crystal structure of CYP102A1 (2HPD) [26]. Blocks
are color-coded as shown and heme is shown in CPK coloring.
DOI: 10.1371/journal.pbio.0040112.g002
Figure 3. Comparison of Library Design to Domains, Dynamics, and
Secondary Structure of CYP102A1
(A) Crossovers in the library designed using the SCHEMA energy function
capture domain boundaries of CYP102A1 determined from molecular
dynamics simulations [27]. Crossovers between blocks 2–3, 4–5, 5–6, and
7–8 lie within a-helices. (Secondary structure assignment is based on the
CYP102A1 crystal structure [24]).
(B) Plot of the RMSD between the backbone atoms of the substrate-
bound (closed) and unbound (open) structures of CYP102A1. The RMSD
was calculated by comparing molecule B of the substrate-free structure
[29] and molecule A of the structure bound to palmitoleic acid [26] using
Swiss PDB Viewer. Vertical lines designate crossover locations and blocks
are numbered. Crossovers between blocks 1–2, 5–6, 6–7, and 7–8 occur
at positions that move , 1.2 A˚ between the two structures. Crossover 3–
4 is located next to a region of high identity and may be shifted towards
the N-terminus by up to 14 residues and still produce the same chimeras.
This shift allows it to occur at a position which moves , 1.2 A˚.
DOI: 10.1371/journal.pbio.0040112.g003
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found that probe hybridization identified the correct frag-
ment at all eight blocks in 31 of 32 sequences. Thus the
sequencing information from probe hybridization reflects the
true sequences of the chimeras with errors in less than 10%
of the chimeras, the majority of which are due to single point
mutations.
Assignment of Folding Status
Using high-throughput CO difference spectroscopy [32],
we assayed clones from the chimeric P450 library for the
characteristic Soret peak at 450 nm. The presence of this
peak indicates correct heme binding and thus a properly
folded P450 heme protein. Of the 628 unique full-length
sequences, 293 (47%) encoded folded P450s. Additional
sequencing of folded P450s yielded an expanded dataset
containing 955 unique sequences (including the three
parents), of which 620 correctly incorporate heme and 335
do not (Table S1). Thirty-eight of these 335 not-folded
sequences gave a peak at 420 nm, characteristic of improperly
incorporated heme and a nonfunctional enzyme [33,34]. The
remaining not-folded sequences lack a compatible heme-
binding site and likely do not fold into a well-defined
structure.
The folded sequences are highly mosaic and differ from
their parents by 72.5 amino acids on average, with as many as
109 amino acid substitutions from the nearest parent
sequence (Figure 1B and Table S1). The average number of
disruptions (,E.) is lower in chimeras that bind heme (29.5)
versus those that do not (34.8). The average number of
mutations in the heme-binding chimeras is also lower, 72.9
versus 77.5. The compositions of chimeras can be easily
visualized using ternary diagrams (Figure 4). For example, the
sequence biases against single A1 and A2 fragments in the
library construction generates fewer chimeras whose compo-
sitions are very close to A1 or A2 (Figure 4A). It is clear from
this plot, however, that the overall compositions of folded
and not-folded chimeras are not markedly different and are
well distributed over the accessible composition space.
Catalytic Activities of Folded P450 Chimeras
We estimated the fraction of chimeras that are functional
by assaying 320 folded P450 chimeras for peroxygenase
activity on 2-phenoxyethanol, a substrate accepted by all
three parents. Reaction on this substrate yields phenol
(Figure 5), which is detectable in high throughput [35]. The
three parent P450s naturally occur as fusion proteins to an
FAD- and FMN-containing NADP reductase [21]. These
monooxygenases use NADPH and molecular oxygen to
hydroxylate fatty acids [22]. The parent heme domains, by
virtue of the single amino acid substitutions F87A in A1 and
F88A in A2 and A3, also function as peroxygenases, catalyzing
oxygen insertion in the presence of hydrogen peroxide
[23,25]. Chimeras that produced at least 25% of the total
product formed in the assay by the most active parent (A1)
were considered active. Of the 320 folded chimeras assayed,
72% were found to be active on 2-phenoxyethanol.
We also assayed all the 955 chimeras for which the
sequences and folding status were determined for activity
on the fatty acid analog p-nitrophenoxydodecanoic acid (12-
pNCA, Figure 5). The parent A1 and A2 heme domains are
Figure 4. Ternary Diagrams Showing the Distribution of Chimera Amino Acid Compositions
(A) Compositions of 955 folded (closed circles) and not-folded (open circles) chimeric sequences. Each data point represents the relative amino acid
identity between a chimera and each parental sequence not including positions conserved between all three parents. This distance was calculated by
determining the number of amino acids a chimera shares with each parent and dividing by their sum. The three relative identities add up to one. Since
each parent shares some sequence identity with the other two, they do not lie at the corners of the diagram.
(B) Compositions of 441 chimeras tested for activity on 12-pNCA: active chimeras (closed circles) and not active (open circles). Chimeras composed
mostly of A3 and chimeras near the center tend to be inactive on 12-pNCA.
DOI: 10.1371/journal.pbio.0040112.g004
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active on 12-pNCA, while A3 is not. Chimeras with 25% of the
total product formed by A1 during the assay were considered
active. None of the chimeras that did not fold properly
showed activity. We then determined activity status for folded
P450s whose concentration was at least 500 nM, in order to
remove false negatives based on low expression or other
experimental errors. Of the folded chimeras, 441 met this
constraint, of which 134 (30%) were active on 12-pNCA
(Table S1). The average number of disruptions is lower for
chimeras active on 12-pNCA versus those that are not (,E.¼
26.3 versus 31.4). Mutations are similarly lower in active
chimeras (,m. ¼ 70.9 versus 76.9).
A ternary diagram showing the 441 chimeras tested for
activity on 12-pNCA (Figure 4B) demonstrates that the
sampled sequences are distributed similarly to the larger
dataset (Figure 4A). Parent A3 is inactive on 12-pNCA, and
there are only a few chimeras with a high fraction of sequence
from A3 that exhibit this activity. Additionally, there is a
lower density of active chimeras near the center, where the
chimeric sequences have the greatest divergence from the
parents.
Fewer chimeras showed activity on 12-pNCA than on 2-
phenoxyethanol, which we attribute to the fact that one
parent, A3, is not active towards 12-pNCA, while all three
parents are active on 2-phenoxyethanol. Overall, 73% of the
folded chimeras assayed exhibited peroxygenase activity on at
least one of these two substrates. Thus, at least 35% of the
6,561 sequences in the library are folded and functional,
corresponding to 2,300 new P450 enzymes, not including any
that are active on substrates not tested. This functional
fraction is roughly three times higher than reported in a
study in which more closely related cytochromes P450 (.71%
amino acid identity) were recombined using a DNA shuffling
methodology that leads to crossovers at regions of high
sequence identity [36].
Thermostabilities of Folded P450 Chimeras
To examine how recombination affects protein stability, we
measured the melting temperatures of the parent P450s and
14 chimeras (all of which denature irreversibly at high
temperature) by monitoring the disappearance of the P450
Soret peak with increasing temperature. A range of Tm’s (42
8C–62 8C) was observed in this small sample (Table 1). The
most stable chimera differs from its closest parent by 84
amino acid substitutions, yet its melting temperature is 7 8C
higher than the most stable parent. It is also higher than that
of a variant of the A1 heme domain previously stabilized by
sequential random mutagenesis and screening [37]. If a
chimera is able to bind heme, then on average its stability
appears not to be compromised relative to the parent
proteins. The ability of the blocks to assemble into more
thermostable proteins when removed from their natural
context supports the modular nature of these elements and
likely reflects some intrinsic stability of the individual blocks,
due to the large number of structural contacts preserved by
the library design.
Logistic Regression Analysis of the Multiple Sequence
Alignments
Small sets of chimeric P450s have been constructed
previously for investigations of sequence-structure-function
relationships [38,39]. The MSA of natural protein families are
also widely used for this purpose. Comprised of sequences
largely uncoupled from natural selection, including sequen-
ces that encode nonnatural functions (such as not folding or
not functioning), the artificial protein family described here
offers a unique opportunity to elucidate key sequence and
structural contributions to P450 folding and function. By
analyzing the MSAs of the chimeric P450s we can identify how
different blocks and their parental identities influence
folding and heme binding or catalytic activity. Because this
dataset also includes sequences that encode not-folded and
not-functional proteins, we can use logistic regression
analysis (LRA), an analog of linear regression suitable for
the type of binary data presented here, to analyze the MSAs.
Other, more commonly used methods such as contingency
table [40,41] and statistical coupling [1,42] are unable to
utilize the additional information provided by the sequences
that do not fold or function.
Underlying our LRA of the folded/not-folded dataset is the
idea that individual fragments and interactions between
fragment pairs contribute to whether a chimera will fold and
bind heme. LRA fits an energy model containing intra- and
inter-fragment terms; the magnitude of each term reflects
how strongly that variable affects the likelihood of folding,
with negative values increasing the likelihood and positive
values decreasing it [20]. If energy is below a threshold, a
chimera is assumed to be folded; otherwise it is not. In order
to avoid overfitting the data, p-value testing is used to
determine which fragments make a significant contribution
to predicting chimera folding status.
We applied LRA to the MSA of the entire set of 955
chimeric P450s in Table S1 to determine which blocks
contribute to folding and correct heme binding. The
resulting energy model includes blocks and block pairs that
are significant with the likelihood ratio test and cross-
validation (see Materials and Methods). This analysis revealed
that blocks 1, 5, and 7 by themselves and the interaction
between blocks 1 and 7 (abbreviated 1–7) contribute
significantly to whether a chimeric P450 folds and binds
heme (Figure 6). All other blocks and block pairs are
apparently to a large extent interchangeable with respect to
whether a chimera folds properly.
As shown in Figure 6A, the intra-fragment terms for
fragments 1.2 and 7.3 have lower energy relative to the other
Figure 5. Substrates and Major Products of P450 Peroxygenase
Reactions with 2-Phenoxyethanol and p-Nitrophenoxydodecanoic Acid
(12-pNCA)
In both cases, hydroxylation yields a hemiacetal which decomposes to
phenolic products detectable in high-throughput assays.
DOI: 10.1371/journal.pbio.0040112.g005
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parents, which means the sequence changes in these frag-
ments are more favorable for heme binding. Blocks 1 and 7
are in fact expected to be important, because they contain
the most residues, the greatest number of intra-fragment
contacts (Figure 6E), and block 1 has the highest average
number of sequence changes, whereas block 7 has the third
most (Figure 6E). In contrast, block 5 has the third fewest
intra-fragment contacts and the second fewest average
number of sequence changes (Figure 6E). At this block,
fragment 5.1 is the least favored of all the fragments for
folding and heme binding (Figure 6A). Parent A1 contains a
deletion relative to A2 and A3 in block 5, which may
contribute to this behavior. We suspect that some of the
importance of block 5 is due to the dynamic nature of
cytochromes P450, similar to what has been observed in
multiple sequence analyses of other protein families [2]. The
F, G, and H helices (in blocks 4 and 5) undergo displacements
of more than 5 A˚ between the substrate-bound and substrate-
free forms of A1 [29], and block 5 moves an average of 3.6 A˚
(Figure 7A). This portion of the enzyme acts as a ‘‘hinge’’ by
which the F and G helices close down upon the substrate.
Because none of the residues in block 5 that contact the heme
differ among the three parents, the importance must stem
from how variable amino acids in block 5 affect dynamics or
interact with conserved residues.
Block pair 1–7 was the only pair revealed by LRA as
significant for folding and incorporation of heme. Blocks 1
and 7 interact extensively to form the b-domain (Figure 7B)
and experience the largest average number of broken
contacts when the blocks are inherited from different
parents. As expected, chimeras that inherit blocks 1 and 7
from the same parent are more likely to fold and bind heme
(Figure 6B). This result supports the core hypothesis of
SCHEMA and other penalizing energy functions [43] which
assign the best possible score to these wild-type interactions.
Inspection of the sequences of the parents in these two
blocks revealed an electrostatic interaction that could
contribute to the pattern of energies in Figure 6B. Residues
56 (block 1) and 344 (block 7) are 2.8 A˚ apart in the A1 crystal
structure (Figure 7B). At position 56, parent A1 contains a
positively charged arginine, A2 has a negatively charged
glutamate, and A3 has a neutral glutamine. Residue 344 is a
glutamate in A1 and A3, but lysine in A2. Thus the interaction
1.1–7.2 pairs arginine and lysine, while 1.2–7.3 pairs gluta-
mate and glutamate, both of which are repulsive.
We repeated the logistic regression analysis to determine
which blocks affect activity on 12-pNCA, independent of
heme binding, by applying LRA to the subset of 441 folded
chimeras for which presence or absence of activity on 12-
pNCA had been determined (Table S1). This analysis revealed
that blocks 2 and 4 by themselves and block pair 1–8
contribute to whether a folded chimera is catalytically active
on this substrate. At blocks 2 and 4, the fragments derived
from parent A3 are detrimental to activity (Figure 6C). These
sequence elements likely account for A39s lack of activity on
this substrate, since sequence from this parent at other blocks
has little affect on 12-pNCA activity in the chimeras. The
Table 1. Thermostabilities of Parent and Chimeric Heme
Domains
Sequencea Tm (8C)
b
A1 55
A2 44
A3 49
23113312 43
23133121 45
32312231 51
22312333 62
32312332 52
32312333 56
21333223 54
12112333 49
12313331 49
11213231 53
22313232 52
21113212 49
22213222 48
32213333 47
aSequence listed as parent sequence (A1 ¼ 1, A2 ¼2, A3 ¼ 3) at each block.
bTm is the average of three measurements. Standard deviations are less than 1 8C.
DOI: 10.1371/journal.pbio.0040112.t001
Figure 6. LRA of MSAs Identified Blocks and Block Pairs That Contribute
to Whether a Chimera Folds and Binds Heme and Whether It Exhibits
Activity on 12-pNCA
(A) Intra-fragment terms in the energy model from LRA of folded/not-
folded sequences indicate that blocks 1, 5, and 7 make significant
contributions to folding and incorporation of heme. Negative energies
increase the likelihood of folding and correctly binding heme while
positive ones decrease it.
(B) The single significant inter-fragment interaction from LRA of folded/
not-folded sequences comes from pair 1–7 and includes the nine energy
terms for pair 1–7, which can be divided into three groups. The on-
diagonal elements (filled black) are the most stabilizing. The three terms
filled gray have roughly average energy. The three white elements are
destabilizing relative to the others.
(C) Significant intra-fragment terms from LRA of the MSA of active/not-
active sequences indicate that blocks 2 and 4 have significant effects on
peroxygenase activity.
(D) The single significant inter-fragment interaction between blocks 1
and 8, showing the nine terms, divided into similar groups as in part B.
(E) Black bars, intra-fragment contacts within each block, as defined by
the SCHEMA distance of 4.5 A˚ [16]. Gray bars, the average number of
sequence changes between each parent.
DOI: 10.1371/journal.pbio.0040112.g006
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importance of block pair 1–8 may reflect a difference
between A1 and A2 with respect to substrate binding: when
A1 or A2 is present at either block 1 or 8, activity is strongly
dependent on whether the other block comes from the same
parent (Figure 6D). This indicates that there are one or more
interactions between blocks 1 and 8 that must be preserved in
order for the enzyme to be active on 12-pNCA.
Residues Contributing to Peroxygenase Activity on 12-
pNCA
We sought to determine what interactions(s) might be
responsible for the importance of the 1–8 pair, using the
sequence differences in parents A1 and A2 for guidance. One
obvious difference occurs at the position corresponding to
Arg47 in fragment 1.1, which is located at the opening of the
active site and is thought to interact with the carboxylate
group of fatty acid substrates [29]. Substitutions of this
residue in the A1 holoenzyme significantly reduce catalytic
activity [44,45]. In A2, the equivalent residue is Gly48, a
residue that favors the binding of polycyclic aromatic
hydrocarbons when present in the A1 holoenzyme [46]. We
tested the importance of R47 to peroxygenase activity by
swapping the residues at position 47/48 in A1 and A2, i.e.,
making the single mutation R47G in A1 and G48R in A2. The
R47G mutation in A1 reduced the initial rate nearly 25 fold
(from 65.9 6 8.5 to 2.7 6 0.5 nmol product/nmol P450/min),
making it comparable to the activity of A2. On the other
hand, the G48R mutation in A2 had no effect on rate. This
suggested to us that G48 in A2 does not interact with the
substrate carboxylate group, as the equivalent residue
appears to do in A1.
We postulated that the different mode of substrate binding
could be facilitated by a positively charged residue elsewhere
in the A2 sequence. Only a small portion of block 8,
consisting of halves of two b-strands (residues 434 to 439), is
located near the active site (Figure 7C). Examination of the
parental sequence alignment in this region (Table S2),
however, revealed no lysines or arginines unique to fragment
8.2. Because fragments 8.1 and 8.3 are equally incompatible
with 1.2 according to the LRA, we looked for a residue
between 434 and 439 that was shared by A1 and A3 but not
A2. Residue 435 in A1 (437 in A2 and A3), which is a
glutamate in A1 and A3 and a glutamine in A2, met these
criteria.
We then swapped these residues by making the E435Q
mutation in A1 and the Q437E mutation in A2. The E435Q
Figure 7. Structural Elements That Contribute Significantly to Proper Folding and Incorporation of Heme and Model of Substrate Binding in CYP102A1
and CYP102A2
(A) Movement of block 5 between open (red) and closed (green) structural forms based on alignment of heme cofactor. The average displacement over
the whole block is 3.6 A˚.
(B) Residues that could contribute to positively and negatively interacting fragments at blocks 1 and 7. Residue 56 (shown as arginine) is an arginine,
glutamate, and glutamine; and residue 344 (shown as glutamate) is a glutamate, lysine, and glutamate in A1, A2, and A3, respectively. The fragment
pairs that result in unfavorable charge–charge interactions for these closely spaced side chains are unfavorable overall for folding and heme
incorporation.
(C) In CYP102A1 the carboxylate group of the fatty acid substrate (in green) interacts with arginine 47 from block 1 (dashed line). Residue 435, from
block 8, and residue 24 may form a salt bridge. Portions of blocks 1 and 8 are shown in purple and grey, respectively.
(D) Proposed model for CYP102A2 showing an alternative binding configuration for the fatty acid substrate. Residue 437 (in block 8) is a glutamine in
A2. Thus in A2, lysine 25 is free to interact with the substrate carboxylate group (dashed line). Structure shown is 1FAG [29]. Amino acid residues are in
black and heme is grey.
DOI: 10.1371/journal.pbio.0040112.g007
PLoS Biology | www.plosbiology.org May 2006 | Volume 4 | Issue 5 | e1120007
Structure-Guided Recombination
mutation in A1 reduced catalytic rate by 8 fold, whereas the
Q437E mutation completely abolished the activity of A2
(Table 2). Having shown this residue to be important to
activity in both parents, we next chose eight inactive chimeras
containing unfavorable 1–8 block combinations to determine
whether swapping these positions could ‘‘rescue’’ the activity.
We introduced the Q437E mutation into four chimeras with
fragments 1.1 and 8.2 and the E435Q mutation into four with
fragments 1.2 and 8.1 (Table 2). This single substitution was
able to confer activity in two of the eight chimeras.
Thus the LRA analysis in combination with mutation
studies uncovered a residue (Glu435/Gln437) previously
unknown to be important for catalytic activity and suggests
a different substrate binding mode in CYP102A2. One
structural explanation for these results is illustrated in Figure
7C and 7D. Since A2 lacks a positive charge at position 48 and
has no unique positively charged residues in the small portion
of block 8 near the active site (or block 8 altogether), we
hypothesized that another sequence change may have caused
a positively charged residue to be made available elsewhere.
Glu435 in A1 appears to participate in a salt bridge with
Lys24, which is roughly 4 A˚ away in the crystal structure. The
equivalent residue 25 is a lysine in A2 and a glutamine in A3.
The lack of a salt bridge partner near Lys25 in A2 could free
Lys25 to interact with the carboxylate tail of the fatty acid
(Figure 7D). In support of this, a single substitution of Gln437
to Glu rescued the activity of a chimera containing A2
sequence at block 8, but A1 sequence at block 1. Conversely,
switching Glu435 to Gln in a chimera containing A1 sequence
at block 8 but A2 sequence at block 1 was also able to rescue
the activity. Of course, this single switch was unable to rescue
activity in six more folded, but inactive chimeras, which
indicates that additional interactions are also important
(such as the contributions from residues in blocks 2 and 4).
SCHEMA-Guided Recombination Creates a Library Rich in
Properly Folded, Highly Mutated Sequences
The approach used here to identify optimal recombination
sites differs from the SCHEMA profile described previously
[14]. Evaluating libraries with randomly sampled crossovers, as
was done here, and a recently developed global optimization
of recombination sites [47] are both preferred over the
SCHEMA profile, which neglects important structural inter-
actions between amino acids distant in the primary sequence.
Based on this design, three cytochromes P450 were divided
into ‘‘building blocks’’ and combinatorially reassembled to
yield a library in which 47% of the members fold and correctly
bind heme. This folded fraction is slightly larger than the
prediction of 40% from the design. The full library therefore
contains an estimated 3,000 unique chimeric P450s, many of
which are highly mutated compared to the parent P450s.
It is interesting to estimate the extent to which SCHEMA
recombination has enriched the library relative to a library
having the same distribution of mutation levels, but made
using random mutagenesis. The fraction of folded proteins in
a random library can be estimated using the protein’s
‘‘neutrality,’’ or probability that a random amino acid
substitution will not disrupt folding. Neutrality m has been
calculated for other proteins and ranges from 0.38 to 0.56 [7].
Using 0.6 as a conservative estimate for P450 neutrality, the
fraction of folded P450s having a mutation distribution
equaling that of the chimeras ( ffr) is given by
ffr ¼ 1N
X109
m¼1
Nm3 mm ð1Þ
where m¼0.60, N¼ total number of mutants (628, equal to the
unique set of randomly sampled chimeras), m ¼ number of
amino acid changes, and Nm ¼ number of mutants with a
given value of m. This yields a fraction folded ffr¼ 6.33 105.
The fraction of folded chimeras in the library is 0.47, giving
an enrichment of 0.47/ffr ¼ 7.5 3 103. Thus, by this
conservative estimate, SCHEMA-guided recombination has
increased the frequency of folded chimeras by nearly four
orders of magnitude.
Conclusions
Protein families generated in the laboratory can be used to
identify regions of the sequence and structure that are
important for folding and function. This approach may be
especially valuable for proteins with few naturally occurring
family members. Datasets such as this one, containing
hundreds of proteins for which functional information can
be determined in high-throughput assays, will be invaluable
for developing and validating structure prediction tools and
for protein sequence-structure-function analysis. Finally, rich
in sequence diversity as well as the ability to fold properly,
these proteins may be sources of novel functions for
laboratory protein evolution.
Materials and Methods
Calculation of SCHEMA disruption. The parent heme-domain
sequences of A1, A2, and A3 were aligned using ClustalW [48] (Table
S2). The number of broken contacts in a chimera E [14,16] is
E ¼
X
i
X
j.i
CijDij ð2Þ
where the Cij are elements of the contact matrix which depend solely
on the protein structure. Specifically, Cij ¼ 1 if residues i and j are
within 4.5 A˚ in the structure of A1 bound to N-palmitoylglycine (1JPZ)
[24]; otherwise Cij¼ 0. The SCHEMA delta function Dij uses only the
parental sequence alignment: Dij¼ 0 if the amino acids found in the
chimera at positions i and j are also found together in any single
parent at the same positions. Otherwise, the i–j contact is considered
broken, and Dij¼ 1.
Table 2. Peroxygenase Activities of Site-Directed Mutants of
Parents CYP102A1 and CYP102A2 and Selected Chimeric Heme
Domains on 12-pNCA
Sequence Wild-Typea Glu435Gln or
Gln437Glub
CYP102A1 65.9 6 8.5 8.9 6 1.7
CYP102A2 2.3 6 0.5 n.d.
11332212 n.d. n.d.
11331312 n.d. 0.8 6 0.3
12232232 n.d. n.d.
13233212 n.d. n.d.
21113211 n.d. n.d.
23213211 n.d. n.d.
22131221 n.d. n.d.
22233211 n.d. 0.9 6 0.1
aAll rates are reported in nmol product/nmol P450/min. Activities , 0.1 were not
detectable (n.d.). Wild-type indicates heme-domain sequence with F87A (A1) or F88A (A2)
mutation.
bThe Glu435Gln mutation was made when block 8 contained fragment 8.1. The
Gln437Glu mutation was made in fragment 8.2.
DOI: 10.1371/journal.pbio.0040112.t002
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Library construction. The heme domains of A1 and A2 were
described previously [25]. The heme domain (first 1,401 nucleotides)
of the A3 gene (a gift from Claes von Wachenfeldt, Lund University)
was subcloned into the BamHI/EcoRI sites of the pCWori expression
vector [49], and the mutation corresponding to F88A was introduced.
The chimeric library was constructed following the SISDC method
[30], using the type IIb restriction endonuclease BsaXI. The full-
length library was ligated into the pCWori vector and transformed
into the catalase-deficient E. coli strain SN0037 [50]. Additional details
can be found in Protocol S1.
Probe hybridization analysis. Probe hybridization was performed
as described [31] and detailed in Protocol S1.
High-throughput carbon monoxide binding assay. Clones grown in
96-well plates were replicated into 500 ll of Luria-Bertani (LB)
medium with 100 lg/ml ampicillin in 2 ml deep-well plates (BD
Falcon, San Jose, CA) and grown in a humidified shaker (Kuhner ISF-
1-W, Birsfelden, Sweden) for 20 h at 210 rpm, 30 8C and 80% relative
humidity. Samples (150 ll) of these saturated cultures were trans-
ferred to 850 ll of terrific broth (TB) medium supplemented with 117
lg/ml ampicillin, 30 lg/ml thiamine, 0.6 mM d-aminolevulinic acid,
and 0.7 mM IPTG. These were grown for 24 h at 210 rpm, 25 8C and
80% relative humidity and harvested by centrifugation at 4 8C, 4,900
3 g. Cell pellets were stored frozen at 20 8C until they were
resuspended in 300 ll of lysis buffer (100 mM Tris [pH 8.2] with 0.5
mg/ml lysozyme and 2 units/ml DNAse) using a pipetting robot
(Beckman Multimek 96, Fullerton, CA). Plates were incubated at
room temperature for 1 h, followed by centrifugation at 4,9003 g for
10 min at 4 8C to clear the lysate. CO binding assays were carried out
as described [32] and detailed in Protocol S1.
Functional assays. Chimeras were assayed for peroxygenase activity
on 12-pNCA in 96-well plate format as described [51]. Reactions were
carried out in a volume of 200 ll with 250 lM 12-pNCA and 20 mM
H2O2 in 100 mM Tris (pH 8.2) at room temperature and monitored at
410 nm for 30 min for accumulation of 4-nitrophenol. Chimeras in
wells with total product formation greater than 25% of the average of
four control wells with the A1 heme domain after 30 min were
considered active (corresponding to . 5 lM product).
Activity on 2-phenoxyethanol was assayed in 96-well plates using
the 4-aminoantipyrine assay (4-AAP), which detects phenol-like
compounds [35]. Reactions were carried out in 120 ll with 1%
DMSO, 1% acetone, 100 mM 2-phenoxyethanol and 20 mM H2O2 in
100 mM N-[2-hydroxyethyl]piperazine-N9-[3-propanesulfonic acid]
(EPPS) [pH 8.2]. Reactions were mixed and left at room temperature
without shaking for 2 h then quenched with 120 ll of 0.1 M NaOH
and 4 M urea. Thirty-six ll of 0.6% 4-AAP was added, the 96-well
plate reader was zeroed at 500 nm, and 36 ll of 0.6% potassium
persulfate was added. After 20 min the A500 was read. Chimeras in
wells with an A500 greater than 25% of the average of four control
wells with the A1 heme domain were considered active, correspond-
ing to . 20 lM product.
Thermostability. Thermostabilities (as described by Tm, the
temperature at which half of the protein is unfolded) were measured
using CO difference spectroscopy to monitor the disappearance of
the Soret band with increasing temperature as described [25].
Logistic regression analysis. The significance of each block (intra-
fragment) and block pair (inter-fragment) was calculated relative to a
reference model with all eight blocks using the likelihood ratio test
[20]. In the case of heme binding, this identified six potentially
significant variables which were collected into a second-round
reference model and reevaluated using the likelihood ratio test
(Table S3). Blocks 1, 5, 7, and block pair 1–7 remained highly
significant in the second round, whereas pairs 1–5 and 5–8 dropped
in significance to p . 103, a threshold established previously [20].
Cross-validation tests (data not shown) provide further evidence that
only the variables 1, 5, 7, and 1–7 are significant. The same analysis
was done for activity on 12-pNCA and determined blocks 2, 4 and 1–8
are significant.
Construction and analysis of site-directed mutants. Single muta-
tions were made in the A1 and A2 genes and in the genes of the eight
chimeras seen in Table 2. The R47G and G48R mutations were made
using the codon from the alternate parent, Arg (CGT) and Gly (GGC),
respectively. The E435Q and Q437E mutations were made in the
same fashion with the codons Glu (GAA) and Gln (CAA) being
swapped. Mutants were constructed using PCR overlap extension
mutagenesis [52], cloned into the BamHI/EcoRI site of pCWori and
transformed into catalase-deficient E. coli. P450 chimeras and parents
were cultured in 200 ml of TB medium and the initial rates on 12-
pNCA were measured with 1 lM enzyme, 250 lM 12-pNCA, 1%
DMSO, 20 mM H2O2 in 100 mM Epps (pH 8.2), as done previously
[25].
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